Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Screening is testing to try to find a disease such as cancer early, in people who don’t have any symptoms of it yet. At this time, there are no widely recommended screening tests for myelodysplastic syndromes (MDS).
MDS is often found when a person sees a doctor because of signs or symptoms they are having, such as feeling very tired, getting infections, or bruising or bleeding easily.
But sometimes MDS is found early, before it even causes symptoms, when a person has an abnormal result on a blood test that was done as part of a routine exam or for some other health reason.
MDS that’s found early does not always need to be treated right away, but it does need to be watched closely for signs that it's progressing.
For some people who have known risk factors for MDS, such as an inherited syndrome or having received certain chemotherapy drugs, doctors might recommend close monitoring with blood tests or other exams or tests to look for possible early signs of MDS.
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Aster JC, Stone RM. Clinical manifestations, diagnosis, and classification of myelodysplastic syndromes (MDS). UpToDate. 2024. Accessed at https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-classification-of-myelodysplastic-syndromes-mds on July 1, 2024.
National Cancer Institute. Myelodysplastic Syndromes Treatment (PDQ®)–Health Professional Version. 2022. Accessed at https://www.cancer.gov/types/myeloproliferative/hp/myelodysplastic-treatment-pdq on July 1, 2024.
Steensma DP, Stone RM. Chapter 96: Myelodysplastic syndromes. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, Pa: Elsevier; 2020.
Last Revised: November 21, 2024
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.